The most important thing to avoid when taking low dose naltrexone (LDN) is any opioid medication. Because LDN works by temporarily blocking opioid receptors, combining it with opioids can trigger withdrawal symptoms or render pain medication ineffective. Beyond opioids, there are several other medications, substances, and situations that require caution or adjustment while on LDN.
Opioid Medications
This is the most critical interaction. LDN blocks the same receptors that opioid painkillers bind to, so taking both at the same time can cause two problems: it can make your pain medication stop working, and if you’re physically dependent on opioids, it can throw you into sudden withdrawal. This applies to prescription painkillers like hydrocodone, oxycodone, morphine, codeine, and fentanyl. It also applies to opioid-based medications used for addiction treatment, including methadone and buprenorphine.
If you’re currently taking any opioid, you need a washout period before starting LDN. Clinical protocols typically require patients to be completely off short-acting opioids for 7 to 10 days and off longer-acting opioids like methadone for at least 10 to 14 days. This gives your body enough time to clear the drugs so that naltrexone doesn’t trigger precipitated withdrawal, which can be severe. Some over-the-counter cough medicines also contain opioid-based ingredients like dextromethorphan or codeine, so check labels carefully.
Alcohol and Liver Strain
Naltrexone is processed through the liver, and at higher doses it has been associated with liver enzyme elevations. In one large clinical trial, about 0.9% of participants developed liver enzymes greater than five times the normal upper limit. While LDN uses a fraction of the standard dose (typically 1.5 to 4.5 mg compared to the standard 50 mg), the drug’s product information still lists acute hepatitis and liver failure as contraindications.
Heavy alcohol use puts additional stress on the liver and raises the risk of compounding any hepatotoxic effects. If you have active liver disease, your prescriber should weigh the risks carefully before starting LDN. For people with healthy livers, routine blood monitoring isn’t typically required at low doses, but avoiding excessive alcohol is a reasonable precaution.
Medications That Need Extra Attention
People often start LDN alongside existing medications for autoimmune conditions, and the question of whether LDN interferes with immunosuppressants comes up frequently. A nationwide registry study of patients with rheumatoid arthritis found that starting LDN did not significantly change the overall doses of disease-modifying drugs, corticosteroids, or biologics that patients used. What did happen over time was that fewer patients in the long-term LDN group continued using biologics (a 23% reduction in users) and fewer continued disease-modifying drugs overall (a 13% reduction). This likely reflects patients whose symptoms improved enough to taper other treatments rather than a dangerous interaction.
There are no well-documented interactions between LDN and common immunosuppressants, but any changes to your existing medication regimen should be made gradually and with your prescriber’s input, not on your own based on how you feel.
Thyroid Medications
Some online communities claim LDN improves thyroid function enough that you can lower your levothyroxine dose. A large quasi-experimental study of 898 patients found no support for this. There was no association between starting LDN and any reduction in thyroid hormone use. If anything, the data showed a slight tendency toward increasing levothyroxine consumption with more LDN exposure. Reducing your thyroid medication based on the assumption that LDN will pick up the slack could leave you hypothyroid.
Timing Around Surgery
If you have an elective surgery coming up, LDN can complicate pain management. Because it blocks opioid receptors, post-surgical opioid painkillers may not work properly if LDN is still active in your system. A review in Regional Anesthesia and Pain Medicine recommends stopping LDN at least 3 days before surgery. This gives naltrexone and its active byproducts enough time to clear so that opioid-based anesthesia and post-operative pain relief can work as intended.
Let your surgeon and anesthesiologist know you take LDN well before your procedure date. Non-opioid pain management strategies can be planned in advance if needed.
Compounding Fillers and Formulation Issues
Because LDN isn’t commercially manufactured at the low doses used (it’s cut down from the standard 50 mg tablet), most people get it from compounding pharmacies. The filler material in your capsule matters more than you might think. Standard compounding uses microcrystalline cellulose as a filler, which is generally well tolerated.
Some compounding pharmacies use calcium carbonate, lactose, or sucrose as fillers instead. Calcium carbonate can potentially affect absorption of other medications you take at the same time. Lactose is a problem if you’re intolerant. And some people with autoimmune conditions report sensitivities to certain sugar-based fillers. When filling your prescription, ask your compounding pharmacy what filler they use and request microcrystalline cellulose or another inert option if you have known sensitivities.
Nighttime Dosing and Sleep Disruption
LDN is traditionally taken at bedtime based on the theory that blocking opioid receptors overnight triggers a rebound increase in your body’s natural endorphin production. But about 1 to 2% of users experience insomnia or intensely vivid dreams that disrupt sleep. If this happens to you, the fix is straightforward: switch to morning dosing. Clinicians who prescribe LDN regularly report that moving the dose to the morning eliminates sleep disturbances for most people without reducing effectiveness. Some practitioners also use twice-daily split dosing as an alternative.
Pregnancy Considerations
Data on LDN during pregnancy is extremely limited. What exists comes from women taking the full 50 mg dose of naltrexone rather than the low doses used in LDN. For breastfeeding, the picture is slightly clearer. Naltrexone passes into breast milk in very small amounts. In one case, an exclusively breastfed infant would have received roughly 0.86% of the mother’s weight-adjusted dose, and the infant showed no adverse effects. A second study found a similarly low relative infant dose of 0.83%. The National Institutes of Health’s lactation database notes that if a mother requires naltrexone, it is not a reason to discontinue breastfeeding. Still, the overall evidence base is small, and decisions about continuing LDN during pregnancy or breastfeeding involve weighing limited data against your individual situation.
Substances That Affect Opioid Receptors
Beyond prescription opioids, several other substances interact with the same receptor system LDN targets. Kratom, a plant-based supplement increasingly used for pain, acts on opioid receptors and can conflict with LDN in the same way prescription opioids do. Ultra-low-dose opioid compounds found in some herbal formulations can also be affected. Even high doses of certain peptides marketed for recovery or anti-aging may have opioid receptor activity. If you take any supplement or substance that produces opioid-like effects (pain relief, euphoria, sedation), assume it could interact with LDN and discuss it with your prescriber before combining them.